aldosterone has been researched along with cediranib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addison, CL; Bar, J; Bradbury, PA; Dimitroulakos, J; Ding, K; Goss, GD; Han, L; Laurie, SA; Seymour, L; Shepherd, FA; Zhao, H | 1 |
1 trial(s) available for aldosterone and cediranib
Article | Year |
---|---|
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.
Topics: Aldosterone; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Canada; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Peptidyl-Dipeptidase A; Predictive Value of Tests; Prognosis; Quinazolines; Survival Analysis; Treatment Outcome | 2015 |